SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001564590-16-027513
Filing Date
2016-11-04
Accepted
2016-11-04 08:46:09
Documents
5
Effectiveness Date
2016-11-04

Document Format Files

Seq Description Document Type Size
1 S-8 atra-s8_20160930.htm S-8 90628
2 EX-5.1 atra-ex51_7.htm EX-5.1 11015
3 EX-23.2 atra-ex232_6.htm EX-23.2 2238
4 GRAPHIC g201611040729130829703.jpg GRAPHIC 2546
5 GRAPHIC g201611040729130929704.jpg GRAPHIC 2546
  Complete submission text file 0001564590-16-027513.txt   112277
Mailing Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080 650-278-8930
Atara Biotherapeutics, Inc. (Filer) CIK: 0001604464 (see all company filings)

IRS No.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-214431 | Film No.: 161973748
SIC: 2836 Biological Products, (No Diagnostic Substances)